Results 1 -
10
of
10
for
Polatuzumab vedotin
- Polatuzumab vedotin-piiq injection is used along with bendamustine (Belrapzo, Treanda) and rituximab (Rituxan) in adults to treat ... treatment with at least two other chemotherapy medications. Polatuzumab vedotin-piiq is in a class of medications called ...
- Non-Hodgkin lymphoma (NHL) options include chemotherapy, radiation, targeted therapy, plasmapheresis, surveillance, stem cell transplant, and surgery. ...
- Non-Hodgkin lymphoma (NHL) options include chemotherapy, radiation, targeted therapy, plasmapheresis, surveillance, stem cell transplant, and surgery. ...
- Lymphoma/Start Here ... Lymphoma ... National Cancer Institute ... Non-Hodgkin lymphoma (NHL) options include chemotherapy, radiation, targeted therapy, plasmapheresis, ...
- Cancer/Treatments and Therapies ... Cancer ... Cancer Chemotherapy/Start Here ... Cancer Chemotherapy ... National Cancer Institute ... From the National Institutes of Health ... List ...
- A list of cancer drugs approved by the Food and Drug Administration (FDA) for non-Hodgkin lymphoma. The list includes generic names, brand names, and common ...
- List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016 (Centers for Disease Control and Prevention)Occupational Health for Health Care Providers/Related Issues ... Occupational Health for Health Care Providers ... Centers for Disease Control and Prevention ... Preventing ...
- LiverTox: Clinical and Research Information on Drug-Induced Liver Injury
(National Library of Medicine) (National Institute of Diabetes and Digestive and Kidney Diseases)
Medicines/Statistics and Research ... Medicines ... Liver Diseases/Statistics and Research ... Liver Diseases ... LiverTox® provides regularly updated, unbiased and easily ... - Breastfeeding/Statistics and Research ... Breastfeeding ... National Library of Medicine ... The LactMed® database contains information on drugs and other chemicals ...
- Lymphoma/Statistics and Research ... Lymphoma ... Hodgkin Lymphoma/Statistics and Research ... Hodgkin Lymphoma ... National Cancer Institute ... From the National Institutes ...